| Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi TI Jensen, NS Mikkelsen, Z Gao, J Foßelteder, G Pabst, E Axelgaard, ... Genome research 31 (11), 2120-2130, 2021 | 53 | 2021 |
| MicroRNAs associated with Von Hippel–Lindau pathway in renal cell carcinoma: a comprehensive review LM Schanza, M Seles, M Stotz, J Fosselteder, GC Hutterer, M Pichler, ... International Journal of Molecular Sciences 18 (11), 2495, 2017 | 48 | 2017 |
| Crosstalk between the Notch signaling pathway and long non-coding RNAs A Reicher, J Foßelteder, LN Kwong, M Pichler Cancer letters 420, 91-96, 2018 | 28 | 2018 |
| Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer J Foßelteder, GA Calin, M Pichler Expert opinion on therapeutic targets 22 (12), 973-976, 2018 | 23 | 2018 |
| Long non-coding RNA PANTR1 is associated with poor prognosis and influences angiogenesis and apoptosis in clear-cell renal cell cancer M Seles, GC Hutterer, J Foßelteder, M Svoboda, M Resel, DA Barth, ... Cancers 12 (5), 1200, 2020 | 15 | 2020 |
| Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody D Tvorogov, CAL Thompson‐Peach, J Foßelteder, M Dottore, F Stomski, ... EMBO reports 23 (4), e52904, 2022 | 14 | 2022 |
| Deficiency of malate-aspartate shuttle component SLC25A12 induces pulmonary metastasis HF Alkan, PW Vesely, H Hackl, J Foßelteder, DR Schmidt, ... Cancer & Metabolism 8, 1-13, 2020 | 13 | 2020 |
| Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities J Foßelteder, G Pabst, T Sconocchia, A Schlacher, L Auinger, K Kashofer, ... Leukemia 37 (4), 843-853, 2023 | 7 | 2023 |
| Engineering oncogenic heterozygous gain-of-function mutations in human hematopoietic stem and progenitor cells T Sconocchia, J Foßelteder, T Köhnke, R Majeti, A Reinisch JoVE (Journal of Visualized Experiments), e64558, 2023 | 5 | 2023 |
| Langerhans cell histiocytosis: current advances in molecular pathogenesis T Sconocchia, J Foßelteder, G Sconocchia, A Reinisch Frontiers in Immunology 14, 1275085, 2023 | 4 | 2023 |
| BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis T Sconocchia, J Foßelteder, L Auinger, E Özkaya, T Benezeder, M Lang, ... Leukemia 37 (11), 2292-2296, 2023 | 1 | 2023 |
| Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells G Pabst, J Foßelteder, A Schlacher, L Auinger, D Martinez-Krams, ... Blood 138, 2160, 2021 | 1 | 2021 |
| Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms CAL Thompson-Peach, J Foßelteder, A Reinisch, D Thomas Bio-protocol 13 (2), 2023 | | 2023 |
| A Calreticulin Neoepitope-Directed Monoclonal Antibody Can Overcome JAK Inhibitor Resistance and Block TPO-Independent Megakaryocyte Differentation D Tvorogov, CAL Thompson-Peach, J Foßelteder, M Dottore, F Stomski, ... Blood 138, 3597, 2021 | | 2021 |
| Introduction and Genetic Correction of Calreticulin Mutations in Human Hematopoietic Stem and Progenitor Cells Sheds Light on MPN Pathogenesis J Foßelteder, A Schlacher, G Pabst, B Amtmann, W Schöll, K Kashofer, ... Blood 138 (Supplement 1), 2541-2541, 2021 | | 2021 |
| 3013–TARGETED INTRODUCTION OF HETEROZYGOUS CALR MUTATIONS INTO HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS MIMICS MPN PATHOGENESIS IN VITRO AND IN VIVO. J Foßelteder, A Rosenberger, G Pabst, B Amtmann, W Schöll, A Wölfler, ... Experimental Hematology 100, S49, 2021 | | 2021 |
| Loss of malate-aspartate shuttle component SLC25A12 induces pulmonary metastasis HF Alkan, PW Vesely, H Hackl, J Foßelteder, MG Vander Heiden, ... bioRxiv, 2020.05. 29.121400, 2020 | | 2020 |
